1. Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy 
L. Boglione, A. De Nicolò, C.S. Cardellino, T. Ruggiero, V. Ghisetti, G. Cariti, G. Di Perri, A. D'Avolio 
Clinical Microbiology and Infection 
Volume 21, Issue 2, Pages 205.e1-205.e3 (February 2015)
DOI: /j.cmi
Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

2. FIG. 1
Differences in the distribution of BOC-S isomer plasma concentrations between patients with or without virologic breakthrough (P = p value).
Clinical Microbiology and Infection  , 205.e1-205.e3DOI: ( /j.cmi )
Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions